Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions

Share


Latest Cancer News


3-Year Survival Improved with Taflinar®/Mekinist® Combination in Advanced Melanoma (July 21, 2016)

Patients with advanced melanoma who were treated with the combination consisting of Taflinar (dabrafenib) plus Mekinist (trametinib) had a significantly improved survival rate at 3 years compared to those... Continue Reading

Amy Gibson Creates FIRST Cancer HairCARE Center for CancerConnect.com (July 19, 2016)

Amy Gibson Author | Emmy Nominated Soap Opera Star | Cancer Hair Loss Expert Leading Hair Loss Consultant Amy Gibson breaks new ground again, creating the Cancer HairCARE Center by Amy Gibson premiering... Continue Reading

Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101 (July 19, 2016)

Loxo Oncology, Inc. (LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that the U.S. Food and Drug Administration... Continue Reading

Summer Camp Support Network for Children Affected by a Parent’s Cancer (July 18, 2016)

Camp Kesem at Syracuse University is a free, week-long summer camp for children affected by a parent’s cancer. Over 3 million children live with a parent with cancer, many more have lost a parent to... Continue Reading

FDA Places Hold on a Trial Evaluating Genetically Engineered Immune Cells for Cancer Treatment (July 18, 2016)

The United States Food and Drug Administration (FDA) has placed a hold on a clinical trial, referred to as the ROCKET trial, due to side effects of the treatment that may be associated with 3 patient deaths. Chimeric... Continue Reading

Study Suggests Men with Metastatic Prostate Cancer Should Be Tested for Inherited Mutations (July 14, 2016)

Ever since inherited mutations in BRCA genes were first linked to breast and ovarian cancer two decades ago, this information has been used as a way to help empower women. Those who have the mutations... Continue Reading

Niraparib Improves Progression-Free Survival in Ovarian Cancer (July 13, 2016)

The PARP inhibitor niraparib improves the time to cancer progression among patients with recurrent ovarian cancer when used as maintenance therapy during platinum-based chemotherapy. Each year in the United... Continue Reading

Syndros™ Approved for Treating Chemotherapy-Induced Nausea and Vomiting (July 12, 2016)

The orally administered liquid formulation, Syndros (dronabinol), has been approved by the United States Food and Drug Administration (FDA) for the treatment of chemotherapy-induced nausea and vomiting.... Continue Reading

Finding Balance: Scenes from a Family (July 11, 2016)

For many women, juggling professional success and family life presents challenges. Bringing home the skills that serve you in the workplace might just help you organize your life at home. By Sarah Shaw,... Continue Reading

Compliments: Accept the Gift with Grace (July 11, 2016)

By Denise King Gillingham, LMSW, ACC, CPM Why is it so hard to listen to nice things about yourself? It seems like it should be so easy—and enjoyable—but many of us react to compliments in ways that... Continue Reading

Writing the Narrative of Illness (July 11, 2016)

The practice of writing can be a valuable therapeutic tool in the face of illness and trauma. By Judith Hannan We are made up of stories. The stories we tell ourselves be­come who we are. We are certain... Continue Reading

It’s in the Genes: Top 5 Things to Know about Genetic Testing (July 11, 2016)

Advances in genetic testing are offering women more information than ever before about their genetic makeup and are providing opportunities for empowered decision-making related to a wide range of health... Continue Reading

Imbruvica® Effective in Newly Diagnosed and Recurrent Chronic Lymphocytic Leukemia (July 11, 2016)

Imbruvica (ibrutinib) produces long-lasting anti-cancer responses among patients with newly diagnosed chronic lymphocytic leukemia (CLL), as well as those who have received prior therapies. These results... Continue Reading

Darzalex™ Effective in Heavily Pre-Treated Multiple Myeloma (July 7, 2016)

The targeted agent Darzalex (daratumumab) produces long-lasting anti-cancer responses among patients with multiple myeloma that has stopped responding to several prior therapies. These results were recently... Continue Reading

Surgery Can Lengthen Survival of Metastatic Kidney Cancer Patients Treated with Targeted Therapies, Study Finds (July 6, 2016)

Surgery to remove a cancerous kidney can often lengthen the lives of patients receiving targeted therapy for metastatic kidney cancer, but only about three in 10 such patients undergo the procedure, according... Continue Reading

West Los Angeles Premier Cancer Prevention 5K Celebrates 15 Years (July 5, 2016)

The Kickin’ Cancer!® 5K Run / Walk / Stroll is the Lynne Cohen Foundation’s flagship event to end women’s cancers through prevention. As a West Los Angeles favorite since 2001, this event celebrates... Continue Reading

Keytruda® Demonstrates Superior Survival Compared to Chemotherapy as First-Line Treatment for Advanced Non-Small Cell Lung Cancer (July 5, 2016)

Teatment with Keytruda® (pembrolizumab) for previously untreated advanced non-small cell lung cancer (NSCLC) whose tumors expressed high levels of PD-1 is superior to standard chemotherapy. Lung cancer... Continue Reading

GlycoMimetics’ GMI-1271 Receives FDA Fast Track Designation for Treatment of Acute Myeloid Leukemia (July 4, 2016)

GlycoMimetics, Inc. has announced that it received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its novel E-selectin antagonist GMI-1271 for treatment of adult patients with... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions


Cancer Types



Headline News by Cancer Type


Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS